Current understanding of the intratumoral microbiome in various tumors
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved..
It is estimated that in the future, the number of new cancer cases worldwide will exceed the 19.3 million recorded in 2020, and the number of deaths will exceed 10 million. Cancer remains the leading cause of human mortality and lagging socioeconomic development. Intratumoral microbes have been revealed to exist in many cancer types, including pancreatic, colorectal, liver, esophageal, breast, and lung cancers. Intratumoral microorganisms affect not only the host immune system, but also the effectiveness of tumor chemotherapy. This review concentrates on the characteristics and roles of intratumoral microbes in various tumors. In addition, the potential of therapies targeting intratumoral microbes, as well as the main challenges currently delaying these therapies, are explored. Furthermore, we briefly summarize existing technical methods used to characterize intratumoral microbes. We hope to provide ideas for exploring intratumoral microbes as potential biomarkers and targets for tumor diagnosis, treatment, and prognostication.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
Cell reports. Medicine - 4(2023), 1 vom: 17. Jan., Seite 100884 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xue, Chen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
16S rRNA |
|---|
| Anmerkungen: |
Date Completed 20.01.2023 Date Revised 13.02.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.xcrm.2022.100884 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35163696X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35163696X | ||
| 003 | DE-627 | ||
| 005 | 20231226051851.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.xcrm.2022.100884 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1172.xml |
| 035 | |a (DE-627)NLM35163696X | ||
| 035 | |a (NLM)36652905 | ||
| 035 | |a (PII)S2666-3791(22)00448-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Xue, Chen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Current understanding of the intratumoral microbiome in various tumors |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.01.2023 | ||
| 500 | |a Date Revised 13.02.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a It is estimated that in the future, the number of new cancer cases worldwide will exceed the 19.3 million recorded in 2020, and the number of deaths will exceed 10 million. Cancer remains the leading cause of human mortality and lagging socioeconomic development. Intratumoral microbes have been revealed to exist in many cancer types, including pancreatic, colorectal, liver, esophageal, breast, and lung cancers. Intratumoral microorganisms affect not only the host immune system, but also the effectiveness of tumor chemotherapy. This review concentrates on the characteristics and roles of intratumoral microbes in various tumors. In addition, the potential of therapies targeting intratumoral microbes, as well as the main challenges currently delaying these therapies, are explored. Furthermore, we briefly summarize existing technical methods used to characterize intratumoral microbes. We hope to provide ideas for exploring intratumoral microbes as potential biomarkers and targets for tumor diagnosis, treatment, and prognostication | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a 16S rRNA | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a challenge | |
| 650 | 4 | |a immune | |
| 650 | 4 | |a intratumoral bacteria | |
| 650 | 4 | |a therapeutic potential | |
| 700 | 1 | |a Chu, Qingfei |e verfasserin |4 aut | |
| 700 | 1 | |a Zheng, Qiuxian |e verfasserin |4 aut | |
| 700 | 1 | |a Yuan, Xin |e verfasserin |4 aut | |
| 700 | 1 | |a Su, Yuanshuai |e verfasserin |4 aut | |
| 700 | 1 | |a Bao, Zhengyi |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Lanjuan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell reports. Medicine |d 2020 |g 4(2023), 1 vom: 17. Jan., Seite 100884 |w (DE-627)NLM310587662 |x 2666-3791 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2023 |g number:1 |g day:17 |g month:01 |g pages:100884 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.xcrm.2022.100884 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2023 |e 1 |b 17 |c 01 |h 100884 | ||